Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 59OTHER 47NIH 14NETWORK 9UNKNOWN 1INDIV 1

Study Type

Interventional 1

Sponsor

Conditions

Esophageal Neoplasms 9Stomach Neoplasms 7Breast Neoplasms 7Rectal Neoplasms 5Brain Neoplasms 4Neoplasms 3Melanoma 3Lung Neoplasms 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Radiation Injuries 2Pain 2Meningeal Carcinomatosis 2Vomiting 1Varicose Veins 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tuberculosis 1Thoracic Neoplasms 1Solitary Pulmonary Nodule 1Solid Tumors 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Skin Diseases 1Sarcoidosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyps 1Non-Muscle Invasive Bladder Neoplasms 1Neutropenia 1Nasopharyngeal Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × UNKNOWN × Neutropenia × Clear all
NCT01285219 2011-01-27

A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy

ChineseAMS

Phase 3 Completed
337 enrolled

Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡